Jiang, C. Y., Navai, N., Tidwell, R. S., Jindal, S., Macaluso, M., Siefker-Radtke, A. O., Goswami, S., Campbell, M. T., Shah, A. Y., Alhalabi, O., Kamat, A. M., Adibi, M., Dinney, C. P., Guo, C. C., Shen, Y., Gao, J., Sharma, P. (2026). Updated results from a pilot trial of neoadjuvant durvalumb in combination with tremelimuab for cisplatin-ineligible high-risk urothelial carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16584